We are live on ! Find out more
2

2Xideas Portfolio holdings

AUM $232M
1-Year Est. Return 4.22%
This Fund
S&P 500
This Quarter Est. Return
+7.26%
1 Year Est. Return
+4.22%
3 Year Est. Return
+40.58%
5 Year Est. Return
+44.98%
10 Year Est. Return
AUM
$1.05B
AUM Growth
+$6.21M
Cap. Flow
-$41.3M
Cap. Flow %
-3.95%
Top 10 Hldgs %
40.65%
Holding
60
New
1
Increased
28
Reduced
29
Closed
2

Top Buys

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$12.2M
2
ABCM
Abcam PLC
ABCM
+$3.59M
3
HALO icon
Halozyme
HALO
+$3.33M
4
CSGP icon
CoStar Group
CSGP
+$2.52M
5
CRL icon
Charles River Laboratories
CRL
+$1.86M

Top Sells

Rank Stock Value
1
OLED icon
Universal Display
OLED
+$15.2M
2
MSCI icon
MSCI
MSCI
+$12.2M
3
TRU icon
TransUnion
TRU
+$11.6M
4
ALGN icon
Align Technology
ALGN
+$4.98M
5
RACE icon
Ferrari
RACE
+$4.84M

Sector Composition

Rank Sector Weight
1 Healthcare 28.47%
2 Technology 25.46%
3 Financials 16.49%
4 Industrials 10.12%
5 Consumer Discretionary 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICE icon
1
Intercontinental Exchange
ICE
$91.1B
$71.5M 6.84%
632,011
-2,257
-0.4% -$244K
IQV icon
2
IQVIA
IQV
$43.1B
$69.6M 6.65%
309,441
+2,526
+0.8% +$507K
ANSS
3
DELISTED
Ansys
ANSS
$64.4M 6.16%
195,138
-11,970
-6% -$3.79M
RMD icon
4
ResMed
RMD
$34.7B
$60.6M 5.79%
277,229
-542
-0.2% -$121K
FTNT icon
5
Fortinet
FTNT
$122B
$30.4M 2.91%
402,535
-55,671
-12% -$3.79M
FAST icon
6
Fastenal
FAST
$57.1B
$28M 2.67%
947,958
-49,678
-5% -$1.36M
NYT icon
7
New York Times
NYT
$11B
$26.9M 2.58%
684,272
-50,956
-7% -$1.94M
KNSL icon
8
Kinsale Capital Group
KNSL
$8.67B
$24.8M 2.37%
66,300
-10,851
-14% -$3.6M
ADI icon
9
Analog Devices
ADI
$175B
$24.5M 2.35%
125,990
-9,633
-7% -$1.78M
SCI icon
10
Service Corp International
SCI
$11.4B
$24.2M 2.32%
375,317
+3,189
+0.9% +$213K
PTC icon
11
PTC
PTC
$17.1B
$23.9M 2.29%
167,993
-1,688
-1% -$224K
HALO icon
12
Halozyme
HALO
$12B
$23.3M 2.23%
645,288
+97,669
+18% +$3.33M
RVTY icon
13
Revvity
RVTY
$14.4B
$22.1M 2.11%
185,806
+5,889
+3% +$724K
ABCM
14
DELISTED
Abcam PLC
ABCM
$21.2M 2.03%
867,416
+208,281
+32% +$3.59M
ENTG icon
15
Entegris
ENTG
$20.6B
$15.8M 1.51%
142,367
-19,639
-12% -$1.79M
ISRG icon
16
Intuitive Surgical
ISRG
$132B
$15.6M 1.49%
45,702
+5,780
+14% +$1.75M
LYV icon
17
Live Nation Entertainment
LYV
$42.3B
$15.2M 1.45%
166,790
+15,530
+10% +$1.21M
CSGP icon
18
CoStar Group
CSGP
$13.1B
$15.1M 1.44%
169,578
+32,693
+24% +$2.52M
KLAC icon
19
KLA
KLAC
$229B
$14.2M 1.36%
+292,480
New +$12.2M
WSO icon
20
Watsco Inc
WSO
$12.8B
$14M 1.34%
36,697
-5,936
-14% -$2.01M
FERG icon
21
Ferguson
FERG
$44.2B
$14M 1.34%
88,788
+4,396
+5% +$626K
VRSK icon
22
Verisk Analytics
VRSK
$25B
$13.8M 1.32%
60,853
+743
+1% +$156K
TYL icon
23
Tyler Technologies
TYL
$15.5B
$13.7M 1.31%
32,921
+99
+0.3% +$38.1K
EW icon
24
Edwards Lifesciences
EW
$52B
$13.3M 1.27%
140,943
-898
-0.6% -$78K
VRTX icon
25
Vertex Pharmaceuticals
VRTX
$137B
$13M 1.25%
37,057
+576
+2% +$194K

Similar funds

2Xideas's Q2 2023 Portfolio in Review

As of Q2 2023, 2Xideas held 60 positions worth $1.05B, up 0.6% from $1.04B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

2Xideas withdrew a net $41.3M in Q2 2023, closing 2 positions and reducing 29 holdings. Its most notable exit was Universal Display, an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Technology and Financials.

Against the trend, 2Xideas opened a new position in KLA worth $14.2M.

  • 2Xideas's largest Q2 2023 buy was KLA: 292,480 shares worth $14.2M.
  • 2Xideas added most to Abcam PLC in Q2 2023, an estimated $3.59M increase.
  • 2Xideas's biggest Q2 2023 reduction was MSCI, cutting an estimated $12.2M.
  • 2Xideas fully exited Universal Display in Q2 2023, selling an estimated $15.2M.
  • 2Xideas's ten largest holdings make up 41% of its $1.05B portfolio in Q2 2023.
  • 2Xideas opened 1 new position and closed 2 in Q2 2023.
  • 2Xideas's portfolio value rose 0.6% quarter-over-quarter to $1.05B.

Based on 2Xideas's 13F filing for Q2 2023, filed 10 Aug 2023.